Literature DB >> 12458156

Pharmacological approaches to discovery and development of new mucolytic agents.

Malcolm King1, Bruce K Rubin.   

Abstract

Airway mucus is the secretory product of the mucous cells; it is a variable mixture of water, mucous glycoproteins, low molecular weight ions, proteins, and lipids, whose physical properties are important for airway defense. The factors that contribute to the physical properties of mucus are complex, and there are a number of pharmacological strategies that can potentially serve to improve the clearability of airway mucus. Novel mucoactive approaches include strategies for mucoregulation--decreasing the abnormal volume of mucus secretion--and medications designed to improve the cough clearability of airway secretions. In vitro results suggest potential benefits from the additive effects of selected combinations of mucoactive medications. Further studies are required to confirm these findings, to perform direct assessments of mucus clearability, and to extend the observations to patients with various types of pulmonary diseases where mucoactive treatments are required. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458156     DOI: 10.1016/s0169-409x(02)00156-4

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  14 in total

1.  Determination of Diclofenac and N-Acetylcysteine by an Optimized Luminescence Method Using CdS Quantum Dots as Sensitizers.

Authors:  Abdolraouf Samadi-Maybodi; Ali Tilehkan; Mohammad-Rasool Sadeghi-Maleki
Journal:  J Fluoresc       Date:  2017-02-14       Impact factor: 2.217

2.  Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.

Authors:  Xiaojian Li; Frederick G Vogt; Don Hayes; Heidi M Mansour
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-02-06       Impact factor: 2.849

Review 3.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

4.  Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma.

Authors:  Anh L Innes; Stephen D Carrington; David J Thornton; Sara Kirkham; Karine Rousseau; Ryan H Dougherty; Wilfred W Raymond; George H Caughey; Susan J Muller; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-07       Impact factor: 21.405

5.  Synthetic tracheal mucus with native rheological and surface tension properties.

Authors:  R Hamed; J Fiegel
Journal:  J Biomed Mater Res A       Date:  2013-06-29       Impact factor: 4.396

6.  A new paradigm in respiratory hygiene: increasing the cohesivity of airway secretions to improve cough interaction and reduce aerosol dispersion.

Authors:  Gustavo Zayas; John Dimitry; Ana Zayas; Darryl O'Brien; Malcolm King
Journal:  BMC Pulm Med       Date:  2005-09-02       Impact factor: 3.317

Review 7.  Secretion properties, clearance, and therapy in airway disease.

Authors:  Bruce K Rubin
Journal:  Transl Respir Med       Date:  2014-03-10

Review 8.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

9.  Heparin and related drugs: beyond anticoagulant activity.

Authors:  Clive Page
Journal:  ISRN Pharmacol       Date:  2013-07-30

10.  A new paradigm in respiratory hygiene: modulating respiratory secretions to contain cough bioaerosol without affecting mucus clearance.

Authors:  Gustavo Zayas; Juan C Valle; Mauricio Alonso; Henry Alfaro; Daniel Vega; Gloria Bonilla; Miguel Reyes; Malcolm King
Journal:  BMC Pulm Med       Date:  2007-08-13       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.